Literature DB >> 2408720

Production of RNA-dependent haemolysin by Haemophilus pleuropneumoniae.

P G Martin, P Lachance, D F Niven.   

Abstract

Five strains of Haemophilus pleuropneumoniae, out of eight strains tested, produced extracellular haemolysin(s) when grown in liquid culture in the presence, but not in the absence, of RNA. The haemolysin produced by the neotype strain was unstable, heat labile, and sensitive to degradation by pronase, trypsin, and chymotrypsin; moreover, trypan blue treated haemolysin preparations were less effective at causing erythrocyte lysis than were untreated preparations. Following growth in the absence of RNA, washed suspensions of the neotype strain produced extracellular haemolysin when incubated in the presence of RNA, glucose, and casein acid hydrolysate; extracellular haemolysin could not be detected if the incubation mixture contained chloramphenicol. The haemolysin produced by washed bacterial suspensions was similar to that produced by growing cultures in that it was unstable, heat labile, and sensitive to inactivation by the same complement of enzymes. Erythrocyte lysis induced by either haemolysin preparation was preceded by a prelytic phase, the duration of which was dependent upon haemolysin concentration and the initial temperature of the haemolysin--erythrocyte mixture. It is concluded that the haemolysin(s) produced by the neotype strain of H. pleuropneumoniae is distinct from, but closely related to both streptolysin S and the haemolysin produced by Treponema hyodysenteriae.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408720     DOI: 10.1139/m85-085

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  14 in total

1.  Serotype-related differences in production and type of heat-labile hemolysin and heat-labile cytotoxin of Actinobacillus (Haemophilus) pleuropneumoniae.

Authors:  E M Kamp; L A van Leengoed
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

2.  Use of an inhibition enzyme-linked immunosorbent assay for quantification of capsular polysaccharide or proteins in vaccines.

Authors:  Thomas J Inzana; Anna Champion
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

3.  Actinobacillus pleuropneumoniae hlyX gene homology with the fnr gene of Escherichia coli.

Authors:  J I MacInnes; J E Kim; C J Lian; G A Soltes
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

4.  Identification of the heat-labile hemolysin of Actinobacillus pleuropneumoniae serotype 1.

Authors:  J Devenish; S Rosendal
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

5.  Tryptone-yeast extract broth as a culture medium for Haemophilus pleuropneumoniae and Haemophilus parasuis to be used as challenge inocula.

Authors:  T O'Reilly; D F Niven
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

6.  Outer membrane protein profiles of Haemophilus pleuropneumoniae.

Authors:  V J Rapp; R S Munson; R F Ross
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Effect of iron restriction on the outer membrane proteins of Actinobacillus (Haemophilus) pleuropneumoniae.

Authors:  H G Deneer; A A Potter
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

8.  Role of lipopolysaccharides in adherence of Actinobacillus pleuropneumoniae to porcine tracheal rings.

Authors:  M Bélanger; D Dubreuil; J Harel; C Girard; M Jacques
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

9.  Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine.

Authors:  P J Fedorka-Cray; M J Huether; D L Stine; G A Anderson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

10.  Actinobacillus pleuropneumoniae culture supernatants interfere with killing of Pasteurella multocida by swine pulmonary alveolar macrophages.

Authors:  W B Chung; L Bäckström; J McDonald; M T Collins
Journal:  Can J Vet Res       Date:  1993-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.